This report is submitted pursuant to the requirements of Nevada Revised Statutes (NRS) 439B.650 and information will be presented in a public hearing as required. Data collected from the 2023 calendar year was utilized to create this report. This report includes data collected from manufacturers, wholesalers, PBMs and drug manufacturer representatives. The process of manufacturing, distributing, and paying for pharmaceuticals involves numerous entities involved in the drug supply chain, including drug manufacturers, wholesalers, pharmacies, pharmacy benefit managers (PBMs), and insurers. Real transaction prices, including rebates and discounts at each stage of this process, are needed to understand profits across the supply chain.